How addictive drugs disrupt presynaptic dopamine neurotransmission
about
Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neuronsAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsLRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activityMechanisms of dopamine transporter regulation in normal and disease statesA current view of serotonin transportersVitamin D receptor and epigenetics in HIV infection and drug abusePharmacotherapy for stimulant-related disordersBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterNeurobiology of adolescent substance use and addictive behaviors: treatment implicationsIllicit dopamine transients: reconciling actions of abused drugsTargeting glutamate uptake to treat alcohol use disordersNitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of CocaineCommon and distinct neural targets of treatment: changing brain function in substance addictionA review of pharmacogenetic studies of substance-related disordersCocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental AreaMechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.Mechanistic insights into nicotine withdrawal.Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine OverdoseDiversity of Dopaminergic Neural Circuits in Response to Drug ExposureHow compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatumIndividual differences in the behavioral effects of nicotine: A review of the preclinical animal literatureMolecular and functional imaging of internet addictionThe neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humansDopaminergic neurons inhibit striatal output through non-canonical release of GABAVesicular integrity in Parkinson's diseaseMechanisms of psychostimulant-induced structural plasticitySegregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulantsChronic ketamine administration modulates midbrain dopamine system in miceAmphetamine elicits opposing actions on readily releasable and reserve pools for dopamineGreater ethanol-induced locomotor activation in DBA/2J versus C57BL/6J mice is not predicted by presynaptic striatal dopamine dynamicsDopamine receptor activation increases HIV entry into primary human macrophagesRole for Rab10 in Methamphetamine-Induced BehaviorPharmacosynthetics: Reimagining the pharmacogenetic approachGlycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD.KCNQ channels show conserved ethanol block and function in ethanol behaviour.Discovering a new anatomical structure in the brain: implications for neuropsychiatry and therapy.Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward.The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of miceTime-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine.
P2860
Q21131062-EE38F6A7-D8A8-4FA1-AC7B-99B29D050CEEQ22251215-39EB0648-1EEA-44FB-AB8D-322324D15283Q24323196-C6137F11-9AB7-45C0-BA90-07346AA410D6Q24598750-1B4D1C0C-C3C6-48A2-B08F-16A1E4E36ACCQ26740309-E2D58AC8-FD1F-468B-A25E-8E8021EA84B0Q26782833-AADE3C0D-9CF7-466E-9A85-7B9541CEAC5DQ26829186-A67339F4-AC23-4643-B004-26A22A47C151Q26829749-CC7D3315-EC03-4763-986F-DC1C1AF74E6DQ26852735-A34CED41-9F8C-4956-9764-C0ECB67DC6E3Q26997102-DF1F8071-290A-464F-84CA-D368954EC3D0Q27002488-45267E47-E834-4A2C-A9BC-9868687CF1EAQ27009552-CFD14B51-FBA7-410B-B1E8-043B7C42C9A9Q27027961-D07497D5-3202-4CC8-A277-41D889DBE69CQ27312296-6F24FA55-E029-4D7F-AB1A-2EDD0EF2B01CQ27320220-77D9EF3B-1A8E-415C-A28B-5D2B1E32922AQ27333086-2687F7BF-6067-4B34-9BE7-7C5F9A01BFC6Q27687645-BE9915D0-8B78-453B-93AE-6A67CC911CA7Q28067373-C38830C7-18B1-4BDC-9843-C82ADF641CCAQ28067590-08147B91-14EB-4032-B87B-3323303465BBQ28078491-370BBFAB-B70D-4090-B92D-603D35803D05Q28087262-A91FE78C-F53A-4C9F-B806-4699355D566EQ28087601-50BEEA56-E9F3-4A30-9138-8FC576EEC0D8Q28236333-2062C05F-12C0-47D5-963A-A4A70F71081DQ28276335-44447055-5EBF-47E1-BB66-CAC30C7FD45AQ28385737-1854D346-1981-4451-A4BA-5F8D1C32BCFFQ28389962-520CBA8A-5ACD-437A-87E8-61AC0E19EF4AQ28395155-3EC4E8A7-7FD2-4F21-84EF-988E64E15626Q28482530-A0D9BCC0-6159-4518-9D04-3B71FE110647Q28487647-06266911-3C34-4BB2-A79C-6DCABF5D4CC1Q28537646-8366AC7D-D012-455F-9AB6-75C6940A3FA2Q28543414-63EBDF9E-1879-461D-ADA0-21123F0F63FDQ28547376-46911B0B-263C-420B-8316-E0F5C3991F3DQ28709274-D8E842C5-C790-4028-B0D0-FE682BCB1201Q30414710-75CFFC99-1893-4D19-9149-AF4A1F324B15Q30460166-36077694-C010-45FA-9195-1105E3597C23Q30485144-71C3C9FB-E2BE-416A-BBE6-FAC6F676A713Q30581669-7437FCD7-91EC-4663-B752-834C2990B28FQ33559498-238FB5EF-096E-47BA-8FC5-53BCCCDB1C15Q33575312-A80B737F-DB2B-4F98-82BB-8C9E5411752EQ33625533-0958503A-8219-47DA-91EF-087C33B22453
P2860
How addictive drugs disrupt presynaptic dopamine neurotransmission
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
How addictive drugs disrupt presynaptic dopamine neurotransmission
@ast
How addictive drugs disrupt presynaptic dopamine neurotransmission
@en
How addictive drugs disrupt presynaptic dopamine neurotransmission
@nl
type
label
How addictive drugs disrupt presynaptic dopamine neurotransmission
@ast
How addictive drugs disrupt presynaptic dopamine neurotransmission
@en
How addictive drugs disrupt presynaptic dopamine neurotransmission
@nl
prefLabel
How addictive drugs disrupt presynaptic dopamine neurotransmission
@ast
How addictive drugs disrupt presynaptic dopamine neurotransmission
@en
How addictive drugs disrupt presynaptic dopamine neurotransmission
@nl
P2860
P3181
P1433
P1476
How addictive drugs disrupt presynaptic dopamine neurotransmission
@en
P2860
P304
P3181
P356
10.1016/J.NEURON.2011.02.010
P407
P50
P577
2011-02-24T00:00:00Z